Peter J. Cnota M.D.

Since 2011, writing, substantially contributing to and reviewing stand alone or in co-operation with external consultants a total of more than 750 medical-pharmacological expert documents for regulatory competent authorities across EU and worldwide for the application and maintenance of drug marketing authorisations.

Managing and performing clinical and nonclinical research into investigative APIs and products of projects with emphasis on phase I to IV clinical development. Creating and execution of drug development plans (e.g., RR-glycopyrrolate, flupirtine). Deputizing the Head of Clinical Research since 2012.

Clinical Research in Human Pharmacology: Study physician & principal investigator in several phase I clinical studies

Medizinische Wissenschaften (MedWiss) & Zulassung / Medical & Regulatory Affairs

Neurophysiological testing and evaluation (e.g. Brain-mapping, Pharmako-EEG, EVPs, psychometrical scaling). Descriptive biostatistics.